Strong Earnings from American Express and Charles Schwab, Bristol Myers’ Drug Trial Misses Endpoint
Key Takeaways: American Express (AXP) reported robust Q2 2025 results, significantly surpassing analyst expectations for both revenue and EPS, driven […]
